Stocks and InvestingStocks and Investing
Wed, August 16, 2017
Tue, August 15, 2017
Mon, August 14, 2017
Fri, August 11, 2017
Thu, August 10, 2017
Wed, August 9, 2017
Tue, August 8, 2017
Mon, August 7, 2017

Douglas Tsao Maintained (TEVA) at Hold with Decreased Target to $23 on, Aug 7th, 2017


Published on 2024-10-25 22:08:57 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of Barclays, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $38 to $23 on, Aug 7th, 2017.

Douglas has made no other calls on TEVA in the last 4 months.



There are 7 other peers that have a rating on TEVA. Out of the 7 peers that are also analyzing TEVA, 6 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Vamil Divan of "Credit Suisse" Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017
  • Irina Rivkind Koffler of "Mizuho" Upgraded from Sell to Hold on, Friday, June 16th, 2017
  • Louise Chen of "Cantor Fitzgerald" Initiated at Hold and Held Target at $31 on, Thursday, June 15th, 2017


This is the rating of the analyst that currently disagrees with Douglas


  • Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017